Insights

The life sciences industry is the most promising sector of the U.S. economy, having already yielded important breakthroughs in genomics, cell and gene therapies and gene editing, to name just a few. The coronavirus crisis has only accelerated interest in this space as there is now renewed attention to eradicating disease and improving population health, irrespective of COVID-19.